Ultimately the plan will be judged by its real-world impact on health outcomes. At this years’ OHE Annual Lecture in September, Professor Anita Charlesworth will offer reflections on the economic ...

The Change Initiative Prevention Programme, delivered in partnership with leading global actors, aims to reframe prevention ...

At the intersection of health and the climate is an urgent crisis. This crisis affects health in ways that are wide-ranging, ...

In this report, we investigate the theory and practice of value-based pricing in the pharmaceuticals industry, and provide recommendations for how implementation of value-based pricing can be enhanced ...

Antimicrobial resistance (AMR) is an urgent global health crisis. AMR infections cause an estimated 1.3 million deaths globally every year, and this number is only projected to rise.

Earlier today, the UK government unveiled the long-awaited NHS Ten Year Plan. Commenting on the Plan, Professor Graham Cookson, Chief Executive of the Office of Health Economics, said: “The hotly ...

US drug pricing policies will have global impacts on innovation and access The knowledge generated through biomedical innovation is a public good. One person’s use does not reduce its availability to ...

In this report, we explore the status of access and uptake for NGS testing for lung cancer in Europe, develop the health economic case for NGS testing, and identify barriers and opportunities for ...

The purpose of this research is to identify the attributes to include in a value framework for orphan medicinal products (OMPs), determine their relative importance using a multi-criteria decision ...

This report contributes to the understanding of people’s proximity to dementia (e.g., people with dementia and their carers forecast) and so the potential future number of people who will be impacted ...

Real-World Evidence (RWE) can provide decision-makers in the healthcare sector with insights into the functioning of health technologies outside of clinical trial settings. In this report, we focus on ...